Literature DB >> 19660652

Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration.

Jessica K Alexander1, Phillip G Popovich.   

Abstract

Traumatic spinal cord injury triggers a complex local inflammatory reaction capable of enhancing repair and exacerbating pathology. The composition and effector potential of the post-injury cellular and molecular immune cascade changes as a function of time and distance from the lesion. Production along this time-space continuum of cytokines, proteases, and growth factors establishes dynamic environments that lead to the death, damage, repair or growth of affected neurons and glia. Microenvironmental cues, therefore, generated by the cells therein, may determine these distinct fates of repair versus pathology. To harness repair, it is necessary to manipulate the assembly and phenotype of cells that comprise the neuroinflammatory response to injury. Here, the potential of the neuroinflammatory response to cause outcomes such as pain, regeneration, and functional recovery is reviewed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660652     DOI: 10.1016/S0079-6123(09)17508-8

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  62 in total

1.  Sialidase enhances recovery from spinal cord contusion injury.

Authors:  Andrea Mountney; Matthew R Zahner; Ileana Lorenzini; Martin Oudega; Lawrence P Schramm; Ronald L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injury.

Authors:  Rajat Sandhir; Eugene Gregory; Yong-Yue He; Nancy E J Berman
Journal:  Neurochem Res       Date:  2011-02-03       Impact factor: 3.996

Review 3.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

4.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

Review 5.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

6.  Hyperbaric oxygen intervention reduces secondary spinal cord injury in rats via regulation of HMGB1/TLR4/NF-κB signaling pathway.

Authors:  Nan Kang; Yong Hai; Jing Yang; Fang Liang; Chun-Jin Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

7.  Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine A.

Authors:  Dou Yu; Devang K Thakor; Inbo Han; Alexander E Ropper; Hariprakash Haragopal; Richard L Sidman; Ross Zafonte; Steven C Schachter; Yang D Teng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

Review 8.  Mesenchymal Stem Cell-Macrophage Choreography Supporting Spinal Cord Repair.

Authors:  Inés Maldonado-Lasunción; Joost Verhaagen; Martin Oudega
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

9.  Sizes and Sufficient Quantities of MSC Microspheres for Intrathecal Injection to Modulate Inflammation in Spinal Cord Injury.

Authors:  Suneel Kumar; Joanne Babiarz; Sayantani Basak; Jae Hwan Kim; Jeffrey Barminko; Andrea Gray; Parry Mendapara; Rene Schloss; Martin L Yarmush; Martin Grumet
Journal:  Nano Life       Date:  2015-12

10.  Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis.

Authors:  Masatoshi Suzuki; Sandra Klein; Elizabeth A Wetzel; Michael Meyer; Jacalyn McHugh; Craig Tork; Antonio Hayes; Clive N Svendsen
Journal:  Exp Neurol       Date:  2009-12-11       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.